[Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers].
Kibal'chich DA, Belolipetskaia VG, Blagodatskikh SV, Martsevich SIu, Rudenko LI, Iatsuk VR · 2011 · Eksperimental'naia i klinicheskaia farmakologiia; 2011
Study findings
After oral Metaprot in healthy adults, mean time to peak concentration was about one hour. The report describes substantial variability and a multimodal distribution of pharmacokinetic parameters.
- Population and setting
- Healthy adult volunteers
- Evidence type
- Analytical / composition study
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Pharmacokinetic or analytical measurements do not establish clinical efficacy or a safe dosing regimen.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Kibal'chich DA, Belolipetskaia VG, Blagodatskikh SV, Martsevich SIu, Rudenko LI, Iatsuk VR. [Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers]. Eksperimental'naia i klinicheskaia farmakologiia; 2011 2011.
Molekul research summary: https://molekul.io/research/bemitil-extra-21870773. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry